Scholarly Index
Mariana Chávez‐MacGregor
The University of Texas MD Anderson Cancer Center; 13,844 total citations; 283 total publications; best world rank #151
The University of Texas MD Anderson Cancer Center
13,844Total citations
283Total publications
52H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 336 | US 172 | 98.96 |
| Advanced Breast Cancer Therapies | Lifetime | 244 | US 115 | 97.95 |
| Breast Lesions and Carcinomas | Lifetime | 291 | US 151 | 97.87 |
| HER2/EGFR in Cancer Research | Lifetime | 503 | US 232 | 97.92 |
| Economic and Financial Impacts of Cancer | Lifetime | 293 | US 188 | 96.67 |
| Global Cancer Incidence and Screening | Lifetime | 584 | US 309 | 97.36 |
| Advances in Oncology and Radiotherapy | Lifetime | 700 | US 343 | 89.74 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 876 | US 355 | 87.85 |
| Male Breast Health Studies | Lifetime | 182 | US 75 | 83.65 |
| Breast Cancer Treatment Studies | 2021-2025 | 229 | US 76 | 97.37 |
| Advanced Breast Cancer Therapies | 2021-2025 | 228 | US 85 | 95.99 |
| Breast Lesions and Carcinomas | 2021-2025 | 151 | US 47 | 93.03 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 253 | US 164 | 92.90 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 236 | US 113 | 86.35 |
| HER2/EGFR in Cancer Research | 2021-2025 | 744 | US 248 | 88.30 |
| Cancer Treatment and Pharmacology | 2021-2025 | 932 | US 304 | 84.01 |
| Cancer Risks and Factors | 2021-2025 | 705 | US 252 | 78.46 |